CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
May 09, 2022 08:30 ET | CVRx, Inc.
Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) --  CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s...
Logo transparent PNG.png
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
March 07, 2022 06:00 ET | PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Worldwide Nerve Repair & Regeneration Industry to 2026 - Availability of Therapies for Treatment of Various Issues Presents Opportunities
March 04, 2022 06:18 ET | Research and Markets
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Global Nerve Repair & Regeneration Market (2021-2026) by Product, Application, Geography, Competitive Analysis and the Impact of Covid-19 with...
Groundbreaking Study Establishes Non-surgical Treatment Modality for Bowel Function in Individuals Living With Spinal Cord Injury
February 17, 2022 10:00 ET | SpineX
LOS ANGELES, Feb. 17, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., today announced the publication of new data in the esteemed neuroscience journal, Frontiers in Neuroscience. This new publication...
Logo transparent PNG.png
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
February 07, 2022 06:00 ET | PathMaker Neurosystems Inc.
BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
22157.jpg
Worldwide Deep Brain Stimulation Devices Industry to 2026 - Key Drivers and Challenges
January 24, 2022 04:48 ET | Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation (DBS) Devices Market, By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type...
logo.png
Nexstim Receives an NBS 5+ System Order from a Customer in the US
January 24, 2022 02:00 ET | Nexstim Oyj
Press release, Helsinki, 24 January 2022 at 9 AM (EET) Nexstim Receives an NBS 5+ System Order from a Customer in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces having...
AABM Logo.png
The Alliance for Advancing Bioelectronic Medicine Launches the First Bioelectronic Medicine Day
January 18, 2022 07:00 ET | Alliance for Advancing Bioelectronic Medicine
Geneva, Switzerland, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The Alliance for Advancing Bioelectronic Medicine (AABM) today announced the official launch of the first Bioelectronic Medicine Day, a global...
22157.jpg
Global Brain Implants Markets, 2021-2028 - Increase in the Prevalence of Neurological Disorders & Growing Demand for Minimally Invasive Neurosurgical Procedures
November 23, 2021 05:18 ET | Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Brain Implants Market Size, Share & Trends Analysis Report 2021-2028 by Product (Deep Brain Stimulator, Vagus Nerve Stimulator, Spinal Cord...
Logo transparent PNG.png
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
October 21, 2021 05:00 ET | PathMaker Neurosystems Inc.
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...